Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bakshi, 2008, MRI in multiple sclerosis: current status and future prospects, Lancet Neurol, 7, 615, 10.1016/S1474-4422(08)70137-6
Polman, 2011, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol, 69, 292, 10.1002/ana.22366
Miller, 2012, Advances in imaging to support the development of novel therapies for multiple sclerosis, Clin Pharmacol Ther, 91, 621, 10.1038/clpt.2011.349
Barkhof, 2009, Imaging outcomes for neuroprotection and repair in multiple sclerosis trials, Nat Rev Neurol, 5, 256, 10.1038/nrneurol.2009.41
Lovblad, 2010, MR imaging in multiple sclerosis: review and recommendations for current practice, AJNR Am J Neuroradiol, 31, 983, 10.3174/ajnr.A1906
Frohman, 2006, Multiple sclerosis — the plaque and its pathogenesis, N Engl J Med, 354, 942, 10.1056/NEJMra052130
Waubant, 2006, Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis, Dis Markers, 22, 235, 10.1155/2006/709869
Yednock, 1992, Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin, Nature, 356, 63, 10.1038/356063a0
Minagar, 2003, Blood-brain barrier disruption in multiple sclerosis, Mult Scler, 9, 540, 10.1191/1352458503ms965oa
Yeung, 2008, Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown, Acta Neuropathol, 115, 635, 10.1007/s00401-008-0364-4
Nag, 2007, Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown, Acta Neuropathol, 114, 459, 10.1007/s00401-007-0274-x
Hawkins, 1990, Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers, Brain, 113, 365, 10.1093/brain/113.2.365
Soon, 2007, Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes, Mult Scler, 13, 884, 10.1177/1352458507076970
Leech, 2007, Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis, Neuropathol Appl Neurobiol, 33, 86, 10.1111/j.1365-2990.2006.00781.x
Misselwitz, 2004, Early MR lymphography with gadofluorine M in rabbits, Radiology, 231, 682, 10.1148/radiol.2313021000
Meding, 2007, Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M, Contrast Media Mol Imaging, 2, 120, 10.1002/cmmi.137
Bendszus, 2008, Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study, Brain, 131, 2341, 10.1093/brain/awn156
Corot, 2006, Recent advances in iron oxide nanocrystal technology for medical imaging, Adv Drug Deliv Rev, 58, 1471, 10.1016/j.addr.2006.09.013
Weinstein, 2010, Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review, J Cereb Blood Flow Metab, 30, 15, 10.1038/jcbfm.2009.192
Wuerfel, 2007, Mouse model mimics multiple sclerosis in the clinico-radiological paradox, Eur J Neurosci, 26, 190, 10.1111/j.1460-9568.2007.05644.x
Tysiak, 2009, Beyond blood brain barrier breakdown — in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI, J Neuroinflammation, 6, 20, 10.1186/1742-2094-6-20
Grenier, 2011, Principles and basic concepts of molecular imaging, Pediatr Radiol, 41, 144, 10.1007/s00247-010-1835-z
Sibson, 2004, MRI detection of early endothelial activation in brain inflammation, Magn Reson Med, 51, 248, 10.1002/mrm.10723
Nahrendorf, 2006, Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis, Circulation, 114, 1504, 10.1161/CIRCULATIONAHA.106.646380
Tsourkas, 2005, In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe, Bioconjug Chem, 16, 576, 10.1021/bc050002e
Schneider, 2009, Acute neuroinflammation in Lewis rats — a model for acute multiple sclerosis relapses, J Neuroimmunol, 213, 84, 10.1016/j.jneuroim.2009.05.015
Shapiro, 2004, MRI detection of single particles for cellular imaging, Proc Natl Acad Sci U S A, 101, 10901, 10.1073/pnas.0403918101
Yang, 2010, Temporal and noninvasive monitoring of inflammatory-cell infiltration to myocardial infarction sites using micrometer-sized iron oxide particles, Magn Reson Med, 63, 33, 10.1002/mrm.22175
McAteer, 2007, von Zur Muhlen C, et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide, Nat Med, 13, 1253, 10.1038/nm1631
Serres, 2009, Systemic inflammatory response reactivates immune-mediated lesions in rat brain, J Neurosci, 29, 4820, 10.1523/JNEUROSCI.0406-09.2009
Serres, 2011, VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis, Faseb J, 25, 4415, 10.1096/fj.11-183772
Man, 2007, Inflammatory cell migration into the central nervous system: a few new twists on an old tale, Brain Pathol, 17, 243, 10.1111/j.1750-3639.2007.00067.x
Carman, 2008, Trans-cellular migration: cell-cell contacts get intimate, Curr Opin Cell Biol, b20, 533, 10.1016/j.ceb.2008.05.007
Wolburg, 2005, Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact, Acta Neuropathol, 109, 181, 10.1007/s00401-004-0928-x
Petry, 2007, Magnetic resonance imaging of human brain macrophage infiltration, Neurotherapeutics, 4, 434, 10.1016/j.nurt.2007.05.005
Beckmann, 2009, In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 1, 272, 10.1002/wnan.16
Bendszus, 2003, Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging, J Neurosci, 23, 10892, 10.1523/JNEUROSCI.23-34-10892.2003
Engberink, 2008, MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO, J Cereb Blood Flow Metab, 28, 841, 10.1038/sj.jcbfm.9600580
Oude Engberink, 2010, Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis, NMR Biomed, 23, 1087, 10.1002/nbm.1536
Anderson, 2004, Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis, Ann Neurol, 55, 654, 10.1002/ana.20066
Stoll, 2009, Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging, Neuroscience, 158, 1151, 10.1016/j.neuroscience.2008.06.045
Dousset, 1999, In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance, Magn Reson Med, 41, 329, 10.1002/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3.0.CO;2-Z
Floris, 2004, Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study, Brain, 127, 616, 10.1093/brain/awh068
Dousset, 1999, Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis, AJNR Am J Neuroradiol, 20, 223
Rausch, 2003, MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE, Magn Reson Med, 50, 309, 10.1002/mrm.10541
Chin, 2009, Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways, J Neuroimmunol, 211, 49, 10.1016/j.jneuroim.2009.03.012
Baeten, 2008, Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging, J Neuroimmunol, 195, 1, 10.1016/j.jneuroim.2007.11.008
Ladewig, 2009, Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study, Exp Neurol, 220, 207, 10.1016/j.expneurol.2009.08.027
Dousset, 2006, MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium, AJNR Am J Neuroradiol, 27, 1000
Vellinga, 2008, Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement, Brain, 131, 800, 10.1093/brain/awn009
Tourdias, 2012, Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging, Radiology, 264, 225, 10.1148/radiol.12111416
Lassmann, 2007, The immunopathology of multiple sclerosis: an overview, Brain Pathol, 17, 210, 10.1111/j.1750-3639.2007.00064.x
Vellinga, 2009, Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study, J Magn Reson Imaging, 29, 774, 10.1002/jmri.21678
Martin, 1995, Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis, Crit Rev Clin Lab Sci, c32, 121, 10.3109/10408369509084683
Brochet, 2006, Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE, Neuroimage, 32, 266, 10.1016/j.neuroimage.2006.03.028
Bradley, 1982, Cellular and extracellular myeloperoxidase in pyogenic inflammation, Blood, 60, 618, 10.1182/blood.V60.3.618.618
Chen, 2006, Querol Sans M, Bogdanov A Jr., Weissleder R. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates, Radiology, 240, 473, 10.1148/radiol.2402050994
Rodriguez, 2010, Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity, J Am Chem Soc, 132, 168, 10.1021/ja905274f
Chen, 2008, Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis, Brain, 131, 1123, 10.1093/brain/awn004
Stoll, 2012, Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 4, 438, 10.1002/wnan.1168
Janjic, 2009, Fluorine-containing nanoemulsions for MRI cell tracking, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 1, 492, 10.1002/wnan.35
Flogel, 2008, In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging, Circulation, 118, 140, 10.1161/CIRCULATIONAHA.107.737890
Weise, 2011, In vivo imaging of inflammation in the peripheral nervous system by (19)F MRI, Exp Neurol, 229, 494, 10.1016/j.expneurol.2011.03.020
Weise, 2011, In vivo imaging of stepwise vessel occlusion in cerebral photothrombosis of mice by 19F MRI, PLoS One, 6, e28143, 10.1371/journal.pone.0028143
Wang, 2011, Quantification of increased cellularity during inflammatory demyelination, Brain, 134, 3590, 10.1093/brain/awr307
Denic, 2011, The relevance of animal models in multiple sclerosis research, Pathophysiology, 18, 21, 10.1016/j.pathophys.2010.04.004
Hammond, 2008, Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron, Ann Neurol, 64, 707, 10.1002/ana.21582
Bagnato, 2011, Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla, Brain, 134, 3602, 10.1093/brain/awr278
Bian, 2012, A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis, Mult Scler
Venneti, 2012, Molecular imaging of microglia/macrophages in the brain, Glia
Banati, 2000, The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity, Brain, 123, 2321, 10.1093/brain/123.11.2321
Debruyne, 2003, PET visualization of microglia in multiple sclerosis patients using [11C]PK11195, Eur J Neurol, 10, 257, 10.1046/j.1468-1331.2003.00571.x
Versijpt, 2005, Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study, Mult Scler, 11, 127, 10.1191/1352458505ms1140oa
Politis, 2012, Increased PK11195 PET binding in the cortex of patients with MS correlates with disability, Neurology, 79, 523, 10.1212/WNL.0b013e3182635645
Chauveau, 2008, Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers, Eur J Nucl Med Mol Imaging, 35, 2304, 10.1007/s00259-008-0908-9
Kiferle, 2011, Positron emission tomography imaging in multiple sclerosis-current status and future applications, Eur J Neurol, 18, 226, 10.1111/j.1468-1331.2010.03154.x
Abourbeh, 2012, Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714, J Neurosci, 32, 5728, 10.1523/JNEUROSCI.2900-11.2012
Nag, 2009, Pathology and new players in the pathogenesis of brain edema, Acta Neuropathol, 118, 197, 10.1007/s00401-009-0541-0
cLucchinetti, 2008, Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis, Brain, 131, 1759, 10.1093/brain/awn098
Tait, 2008, Water movements in the brain: role of aquaporins, Trends Neurosci, 31, 37, 10.1016/j.tins.2007.11.003
Saadoun, 2010, Aquaporin-4 in brain and spinal cord oedema, Neuroscience, 168, 1036, 10.1016/j.neuroscience.2009.08.019
Tourdias, 2011, Differential aquaporin 4 expression during edema build-up and resolution phases of brain inflammation, J Neuroinflammation, 8, 143, 10.1186/1742-2094-8-143
Saadoun, 2005, Involvement of aquaporin-4 in astroglial cell migration and glial scar formation, J Cell Sci, 118, 5691, 10.1242/jcs.02680
Auguste, 2007, Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury, Faseb J, 21, 108, 10.1096/fj.06-6848com
Li, 2009, Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice, BMC Neurosci, 10, 94, 10.1186/1471-2202-10-94
Li, 2011, Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation, Faseb J, 25, 1556, 10.1096/fj.10-177279
Ratelade, 2012, Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies, Int J Biochem Cell Biol, 44, 1519, 10.1016/j.biocel.2012.06.013
Shinohara, 2012, Predicting breakdown of the blood-brain barrier in multiple sclerosis without contrast agents, AJNR Am J Neuroradiol, 33, 1586, 10.3174/ajnr.A2997
Ropele, 2011, Relaxation time mapping in multiple sclerosis, Expert Rev Neurother, 11, 441, 10.1586/ern.10.129
Laule, 2004, Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study, J Neurol, 251, 284, 10.1007/s00415-004-0306-6
Vavasour, 2009, Longitudinal changes in myelin water fraction in two MS patients with active disease, J Neurol Sci, 276, 49, 10.1016/j.jns.2008.08.022
MacKay, 2009, MR relaxation in multiple sclerosis, Neuroimaging Clin N Am, 19, 1, 10.1016/j.nic.2008.09.007
Le Bihan, 2003, Looking into the functional architecture of the brain with diffusion MRI, Nat Rev Neurosci, 4, 469, 10.1038/nrn1119
Tievsky, 1999, Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions, AJNR Am J Neuroradiol, 20, 1491
Le Bihan, 2007, The “wet mind”: water and functional neuroimaging, Phys Med Biol, 52, R57, 10.1088/0031-9155/52/7/R02
Balashov, 2012, Acute demyelinating lesions with restricted diffusion in multiple sclerosis, Mult Scler, 10.1177/1352458512445407
Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann Neurol, 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
Lassmann, 2003, Hypoxia-like tissue injury as a component of multiple sclerosis lesions, J Neurol Sci, 206, 187, 10.1016/S0022-510X(02)00421-5
Tourdias, 2011, Adapted focal experimental autoimmune encephalomyelitis to allow MRI exploration of multiple sclerosis features, Exp Neurol, 230, 248, 10.1016/j.expneurol.2011.04.023
Papadopoulos, 2008, Potential utility of aquaporin modulators for therapy of brain disorders, Prog Brain Res, 170, 589, 10.1016/S0079-6123(08)00446-9
Tourdias, 2009, Aquaporin 4 correlates with apparent diffusion coefficient and hydrocephalus severity in the rat brain: a combined MRI-histological study, Neuroimage, 47, 659, 10.1016/j.neuroimage.2009.04.070
Badaut, 2011, Brain water mobility decreases after astrocytic aquaporin-4 inhibition using RNA interference, J Cereb Blood Flow Metab, 31, 819, 10.1038/jcbfm.2010.163
Rovira, 2009, A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis, Arch Neurol, 66, 587, 10.1001/archneurol.2009.49
Kappos, 2007, Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study, Lancet, 370, 389, 10.1016/S0140-6736(07)61194-5
Trojano, 2007, New natural history of interferon-beta-treated relapsing multiple sclerosis, Ann Neurol, 61, 300, 10.1002/ana.21102
Yong, 2002, Differential mechanisms of action of interferon-beta and glatiramer aetate in MS, Neurology, 59, 802, 10.1212/WNL.59.6.802
Gaitan, 2011, Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions, Ann Neurol, 70, 22, 10.1002/ana.22472
Wuerfel, 2010, Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation, J Neuroinflammation, 7, 70, 10.1186/1742-2094-7-70
Compston, 2006, Making progress on the natural history of multiple sclerosis, Brain, 129, 561, 10.1093/brain/awl034
Bonzano, 2009, Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials?, Mult Scler, 15, 1043, 10.1177/1352458509106610
Smith, 2003, Biomarkers in imaging: realizing radiology's future, Radiology, 227, 633, 10.1148/radiol.2273020518
Sormani, 2009, Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach, Ann Neurol, 65, 268, 10.1002/ana.21606
Sormani, 2010, Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach, Neurology, 75, 302, 10.1212/WNL.0b013e3181ea15aa
Sormani, 2009, MRI as an outcome in multiple sclerosis clinical trials, Neurology, 73, 1932, 10.1212/WNL.0b013e3181bd6b8f
Daumer, 2009, MRI as an outcome in multiple sclerosis clinical trials, Neurology, 72, 705, 10.1212/01.wnl.0000336916.38629.43
Held, 2005, Predictors of relapse rate in MS clinical trials, Neurology, 65, 1769, 10.1212/01.wnl.0000187122.71735.1f
Deloire, 2004, Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment, Mult Scler, 10, 540, 10.1191/1352458504ms1090oa
Rausch, 2004, Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging, J Magn Reson Imaging, 20, 16, 10.1002/jmri.20057
Forghani, 2012, Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target, Radiology, 263, 451, 10.1148/radiol.12111593
Wiendl, 2008, Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations, J Neurol, 255, 1449, 10.1007/s00415-008-0061-1
Ros, 1995, Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions, Radiology, 196, 481, 10.1148/radiology.196.2.7617864
Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N Engl J Med, 348, 2491, 10.1056/NEJMoa022749
Bernd, 2009, Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program, Invest Radiol, 44, 336, 10.1097/RLI.0b013e3181a0068b
Hsiao, 2008, Macrophage physiological function after superparamagnetic iron oxide labeling, NMR Biomed, 21, 820, 10.1002/nbm.1260
Schafer, 2008, The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution, Cell Transplant, 17, 923, 10.3727/096368908786576480
Levine, 2004, The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis, Ann N Y Acad Sci, 1012, 252, 10.1196/annals.1306.021